IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Danish Phase 1/2 biotech using AI to develop immuno-oncology therapies.
Industry: Health Care
Latest Trade: $0.60 0.00 (0.0%)
First Day Return: -1.1%
Return from IPO: -94.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/08/2021 |
Offer Price | $10.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $30 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/04/2021 |
Offer Price | $10.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 3.0 |
Deal Size ($mm) | $30 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Oppenheimer & Co. |
Ladenburg Thalmann |
Company Data | |
---|---|
Headquarters | Copenhagen, Denmark |
Founded | 2008 |
Employees | 35 |
Website www.evaxion-biotech.com |